id	sid	eid	entity	type
admet-881	1	1	375	CARDINAL
admet-881	1	2	8(4	CARDINAL
admet-881	1	3	2020	DATE
admet-881	1	4	375	CARDINAL
admet-881	1	5	issn	PERSON
admet-881	1	6	1848-7718	DATE
admet-881	1	7	david dahlgren	PERSON
admet-881	1	8	erik sjögren	PERSON
admet-881	1	9	hans lennernäs	PERSON
admet-881	1	10	uppsala university	ORG
admet-881	1	11	sweden	GPE
admet-881	1	12	hans.lennernas@farmbio.uu.se	PERSON
admet-881	2	1	18 471 4317	CARDINAL
admet-881	2	2	18 471 4223	CARDINAL
admet-881	2	3	june 26, 2020	DATE
admet-881	2	4	september 10, 2020	DATE
admet-881	2	5	september 17, 2020	DATE
admet-881	4	1	fed	ORG
admet-881	6	1	four	CARDINAL
admet-881	7	1	2020	DATE
admet-881	12	1	biopharmaceutics	ORG
admet-881	15	1	1,2	CARDINAL
admet-881	16	1	3	CARDINAL
admet-881	17	1	one	CARDINAL
admet-881	17	2	h. lennernäs et al	PERSON
admet-881	17	3	8(4	CARDINAL
admet-881	17	4	2020	DATE
admet-881	17	5	375	CARDINAL
admet-881	18	1	4,5	CARDINAL
admet-881	20	1	6	CARDINAL
admet-881	22	1	100 %	PERCENT
admet-881	24	1	7	CARDINAL
admet-881	26	1	10-12	CARDINAL
admet-881	27	1	13	CARDINAL
admet-881	28	1	two	CARDINAL
admet-881	29	1	first	ORDINAL
admet-881	30	1	1	CARDINAL
admet-881	31	1	1	CARDINAL
admet-881	33	1	the noyes-whitney/nernst-brunner	ORG
admet-881	33	2	1	CARDINAL
admet-881	34	1	14	CARDINAL
admet-881	36	1	1	CARDINAL
admet-881	36	2	4πr2	WORK_OF_ART
admet-881	36	3	8(4	CARDINAL
admet-881	36	4	2020	DATE
admet-881	36	5	375	CARDINAL
admet-881	36	6	377	CARDINAL
admet-881	36	7	abl	ORG
admet-881	37	1	fick	PERSON
admet-881	37	2	1	CARDINAL
admet-881	38	1	19	CARDINAL
admet-881	39	1	noyes-whitney/nernst-brunner	ORG
admet-881	39	2	1	CARDINAL
admet-881	39	3	16	CARDINAL
admet-881	40	1	about 1 µm	CARDINAL
admet-881	40	2	abl	ORG
admet-881	40	3	2	CARDINAL
admet-881	40	4	20,21	CARDINAL
admet-881	41	1	3	CARDINAL
admet-881	42	1	2	CARDINAL
admet-881	42	2	2	CARDINAL
admet-881	43	1	kelvin	PERSON
admet-881	43	2	20	CARDINAL
admet-881	47	1	first	ORDINAL
admet-881	47	2	10	CARDINAL
admet-881	47	3	1 %	PERCENT
admet-881	48	1	secondly	ORDINAL
admet-881	50	1	1	CARDINAL
admet-881	51	1	fed	ORG
admet-881	52	1	1	CARDINAL
admet-881	54	1	h. lennernäs et	PERSON
admet-881	54	2	al. admet &	ORG
admet-881	54	3	8(4	CARDINAL
admet-881	54	4	2020	DATE
admet-881	54	5	375	CARDINAL
admet-881	55	1	16	CARDINAL
admet-881	57	1	22	CARDINAL
admet-881	58	1	three	CARDINAL
admet-881	59	1	23-25	CARDINAL
admet-881	60	1	two	CARDINAL
admet-881	60	2	26	CARDINAL
admet-881	61	1	1	CARDINAL
admet-881	62	1	bcs ii apis	PERSON
admet-881	62	2	nanosuspensions	PERSON
admet-881	62	3	27	CARDINAL
admet-881	63	1	450	CARDINAL
admet-881	63	2	4.7	CARDINAL
admet-881	63	3	5	CARDINAL
admet-881	63	4	2 μm	QUANTITY
admet-881	63	5	6.8	CARDINAL
admet-881	64	1	28	CARDINAL
admet-881	65	1	29	CARDINAL
admet-881	67	1	30	CARDINAL
admet-881	70	1	31	CARDINAL
admet-881	71	1	32	CARDINAL
admet-881	76	1	four	CARDINAL
admet-881	76	2	fenofibrate	ORG
admet-881	77	1	fed	ORG
admet-881	80	1	1000	CARDINAL
admet-881	80	2	33	CARDINAL
admet-881	81	1	bcs ii	ORG
admet-881	81	2	28,34	CARDINAL
admet-881	82	1	8(4	CARDINAL
admet-881	82	2	2020	DATE
admet-881	82	3	375	CARDINAL
admet-881	82	4	379	CARDINAL
admet-881	83	1	8	CARDINAL
admet-881	85	1	29,38,39	CARDINAL
admet-881	86	1	40	CARDINAL
admet-881	87	1	mucus	ORG
admet-881	90	1	about 120 μm	CARDINAL
admet-881	90	2	480 μm	QUANTITY
admet-881	90	3	830 μm	QUANTITY
admet-881	90	4	a few hours	TIME
admet-881	91	1	43	CARDINAL
admet-881	93	1	46	CARDINAL
admet-881	95	1	around 100–300	CARDINAL
admet-881	97	1	100	CARDINAL
admet-881	97	2	500	CARDINAL
admet-881	100	1	49	CARDINAL
admet-881	103	1	50-53	CARDINAL
admet-881	104	1	2	CARDINAL
admet-881	105	1	three	CARDINAL
admet-881	105	2	3,54	CARDINAL
admet-881	107	1	54	CARDINAL
admet-881	108	1	55	CARDINAL
admet-881	109	1	h. lennernäs et	PERSON
admet-881	109	2	al. admet &	ORG
admet-881	109	3	8(4	CARDINAL
admet-881	109	4	2020	DATE
admet-881	109	5	375	CARDINAL
admet-881	109	6	2	CARDINAL
admet-881	110	1	1	CARDINAL
admet-881	110	2	2	CARDINAL
admet-881	110	3	3	CARDINAL
admet-881	110	4	4	CARDINAL
admet-881	110	5	5	CARDINAL
admet-881	110	6	6	CARDINAL
admet-881	112	1	one	CARDINAL
admet-881	112	2	3	CARDINAL
admet-881	112	3	3	CARDINAL
admet-881	112	4	qin	PERSON
admet-881	113	1	56	CARDINAL
admet-881	114	1	57	CARDINAL
admet-881	115	1	4	CARDINAL
admet-881	116	1	4	CARDINAL
admet-881	116	2	5	CARDINAL
admet-881	118	1	5	CARDINAL
admet-881	120	1	55	CARDINAL
admet-881	121	1	6	CARDINAL
admet-881	121	2	8(4	CARDINAL
admet-881	121	3	2020	DATE
admet-881	121	4	375	CARDINAL
admet-881	121	5	381	CARDINAL
admet-881	121	6	1	CARDINAL
admet-881	122	1	6	CARDINAL
admet-881	122	2	14c]-peg 4000	DATE
admet-881	123	1	the jejunal peff	ORG
admet-881	123	2	7	CARDINAL
admet-881	124	1	59	CARDINAL
admet-881	125	1	7	CARDINAL
admet-881	126	1	four	CARDINAL
admet-881	126	2	four	CARDINAL
admet-881	127	1	2	CARDINAL
admet-881	129	1	2	CARDINAL
admet-881	130	1	55,60	CARDINAL
admet-881	130	2	55	CARDINAL
admet-881	130	3	60	CARDINAL
admet-881	131	1	60	CARDINAL
admet-881	131	2	337	CARDINAL
admet-881	131	3	361	CARDINAL
admet-881	131	4	37 °	QUANTITY
admet-881	131	5	0.5	CARDINAL
admet-881	131	6	0.37	CARDINAL
admet-881	131	7	0.25	CARDINAL
admet-881	131	8	3.7	CARDINAL
admet-881	131	9	4.7 6.9	CARDINAL
admet-881	131	10	10 -6 cm	QUANTITY
admet-881	131	11	14.15	CARDINAL
admet-881	131	12	2.6 170 220	TIME
admet-881	131	13	61	CARDINAL
admet-881	132	1	534 da	QUANTITY
admet-881	133	1	2.4	CARDINAL
admet-881	133	2	9.2	CARDINAL
admet-881	133	3	6.5	CARDINAL
admet-881	134	1	1.7·10−4 cm/s	QUANTITY
admet-881	135	1	62	CARDINAL
admet-881	136	1	1.7·10−4 cm	QUANTITY
admet-881	136	2	63	CARDINAL
admet-881	137	1	64	CARDINAL
admet-881	138	1	merck & co., inc.	ORG
admet-881	138	2	nj	ORG
admet-881	138	3	200	CARDINAL
admet-881	139	1	65	CARDINAL
admet-881	142	1	first	ORDINAL
admet-881	142	2	66	CARDINAL
admet-881	143	1	650	CARDINAL
admet-881	143	2	150	CARDINAL
admet-881	144	1	peg-4000 0.13 mg/ml	QUANTITY
admet-881	144	2	20 mg/ml	QUANTITY
admet-881	144	3	20 mg/ml	QUANTITY
admet-881	144	4	6 mg/ml	QUANTITY
admet-881	145	1	h. lennernäs et	PERSON
admet-881	145	2	al. admet &	ORG
admet-881	145	3	8(4	CARDINAL
admet-881	145	4	2020	DATE
admet-881	145	5	375	CARDINAL
admet-881	148	1	360.4 da	QUANTITY
admet-881	148	2	5.24	CARDINAL
admet-881	148	3	0.1 mg/ml	QUANTITY
admet-881	150	1	60 %	PERCENT
admet-881	150	2	25 %	PERCENT
admet-881	151	1	69	CARDINAL
admet-881	152	1	226	CARDINAL
admet-881	152	2	118 µm	MONEY
admet-881	152	3	26	CARDINAL
admet-881	152	4	70	CARDINAL
admet-881	153	1	takano et al	PERSON
admet-881	154	1	three	CARDINAL
admet-881	154	2	70	CARDINAL
admet-881	155	1	50	CARDINAL
admet-881	155	2	200	CARDINAL
admet-881	156	1	28,34,71	CARDINAL
admet-881	158	1	200	CARDINAL
admet-881	158	2	20	CARDINAL
admet-881	158	3	5	CARDINAL
admet-881	159	1	1.7	CARDINAL
admet-881	159	2	10-4 cm	QUANTITY
admet-881	159	3	abl	ORG
admet-881	160	1	fassif	ORG
admet-881	161	1	fed	ORG
admet-881	162	1	72-75	CARDINAL
admet-881	163	1	76	CARDINAL
admet-881	165	1	77	CARDINAL
admet-881	166	1	4	CARDINAL
admet-881	166	2	3	CARDINAL
admet-881	167	1	fassif	PERSON
admet-881	167	2	64	CARDINAL
admet-881	167	3	4.8	CARDINAL
admet-881	168	1	1.6-fold	CARDINAL
admet-881	169	1	3	CARDINAL
admet-881	170	1	8(4	CARDINAL
admet-881	170	2	2020	DATE
admet-881	170	3	375	CARDINAL
admet-881	170	4	383	CARDINAL
admet-881	170	5	3	CARDINAL
admet-881	170	6	aprepitant nanoand microsuspensions	ORG
admet-881	170	7	2018	DATE
admet-881	171	1	78	CARDINAL
admet-881	172	1	10	CARDINAL
admet-881	172	2	× cm 2	PRODUCT
admet-881	172	3	2.91	CARDINAL
admet-881	172	4	1.02	CARDINAL
admet-881	172	5	0.104	CARDINAL
admet-881	172	6	0.081	CARDINAL
admet-881	172	7	3.57	CARDINAL
admet-881	172	8	1.97	CARDINAL
admet-881	172	9	1.58	CARDINAL
admet-881	172	10	2.10	CARDINAL
admet-881	172	11	2.25	CARDINAL
admet-881	172	12	1.69	CARDINAL
admet-881	172	13	6.63	CARDINAL
admet-881	172	14	7.32	CARDINAL
admet-881	172	15	fed	ORG
admet-881	173	1	two	CARDINAL
admet-881	175	1	0.63 ± 0.05	MONEY
admet-881	175	2	10-4 cm	QUANTITY
admet-881	175	3	1.01 ± 0.09	MONEY
admet-881	175	4	10-4 cm	QUANTITY
admet-881	176	1	55	CARDINAL
admet-881	177	1	1.65 ± 0.53	MONEY
admet-881	177	2	10-4 cm	QUANTITY
admet-881	179	1	54,79,80	CARDINAL
admet-881	180	1	approximately 50 % and 83 %	PERCENT
admet-881	180	2	4	CARDINAL
admet-881	181	1	more than two-fold	CARDINAL
admet-881	182	1	60 %	PERCENT
admet-881	182	2	4	CARDINAL
admet-881	183	1	4	CARDINAL
admet-881	184	1	 s.d	PERSON
admet-881	184	2	fed	ORG
admet-881	185	1	10 -4 cm	QUANTITY
admet-881	186	1	0.63	CARDINAL
admet-881	186	2	0.14 0.34  0.08	QUANTITY
admet-881	186	3	29	CARDINAL
admet-881	187	1	2 5	DATE
admet-881	187	2	6 13	DATE
admet-881	187	3	10 -4 cm	QUANTITY
admet-881	187	4	0.9	CARDINAL
admet-881	188	1	0.4 2.3	QUANTITY
admet-881	188	2	0.4 0.33	CARDINAL
admet-881	188	3	0.09 fabs (%	PERCENT
admet-881	188	4	36	CARDINAL
admet-881	189	1	4 17	DATE
admet-881	189	2	4	CARDINAL
admet-881	189	3	150	CARDINAL
admet-881	189	4	650	CARDINAL
admet-881	192	1	2.5	CARDINAL
admet-881	193	1	55	CARDINAL
admet-881	197	1	h. lennernäs et	PERSON
admet-881	197	2	al. admet &	ORG
admet-881	197	3	8(4	CARDINAL
admet-881	197	4	2020	DATE
admet-881	197	5	375	CARDINAL
admet-881	197	6	384	PRODUCT
admet-881	199	1	fed	ORG
admet-881	200	1	abl	ORG
admet-881	206	1	approximately 60	CARDINAL
admet-881	207	1	60	CARDINAL
admet-881	212	1	63	CARDINAL
admet-881	217	1	81	CARDINAL
admet-881	219	1	biopharmaceutics	ORG
admet-881	220	1	1,82	CARDINAL
admet-881	220	2	fed	ORG
admet-881	220	3	fed	ORG
admet-881	220	4	csa	GPE
admet-881	221	1	37,55,83,84	CARDINAL
admet-881	223	1	69 %	PERCENT
admet-881	223	2	73 %	PERCENT
admet-881	223	3	8(4	CARDINAL
admet-881	223	4	2020	DATE
admet-881	223	5	375	CARDINAL
admet-881	223	6	385 66 %	PERCENT
admet-881	223	7	22 %	PERCENT
admet-881	223	8	85	CARDINAL
admet-881	226	1	three	CARDINAL
admet-881	227	1	three	CARDINAL
admet-881	227	2	86	CARDINAL
admet-881	228	1	1:8	CARDINAL
admet-881	234	1	one	CARDINAL
admet-881	234	2	fed	ORG
admet-881	235	1	37	CARDINAL
admet-881	236	1	fed	ORG
admet-881	237	1	fed	ORG
admet-881	238	1	39	CARDINAL
admet-881	239	1	90	CARDINAL
admet-881	241	1	fed	ORG
admet-881	246	1	1	CARDINAL
admet-881	246	2	b. abrahamsson	PERSON
admet-881	246	3	m. mcallister	PERSON
admet-881	246	4	p. augustijns	PERSON
admet-881	246	5	p. zane	PERSON
admet-881	246	6	j. butler	PERSON
admet-881	246	7	r. holm	PERSON
admet-881	246	8	a. lindahl	PERSON
admet-881	246	9	a. müllertz	PERSON
admet-881	246	10	x. pepin	PERSON
admet-881	247	1	six years	DATE
admet-881	248	1	european journal of pharmaceutics	ORG
admet-881	248	2	biopharmaceutics	ORG
admet-881	248	3	2020	DATE
admet-881	249	1	h. lennernäs et	PERSON
admet-881	249	2	al. admet &	ORG
admet-881	249	3	8(4	CARDINAL
admet-881	249	4	2020	DATE
admet-881	249	5	375	CARDINAL
admet-881	249	6	2	CARDINAL
admet-881	249	7	e. sjögren	PERSON
admet-881	249	8	b. abrahamsson	PERSON
admet-881	249	9	p. augustijns	PERSON
admet-881	249	10	d. becker	PERSON
admet-881	249	11	m.b. bolger	PERSON
admet-881	249	12	m. brewster	PERSON
admet-881	249	13	j. brouwers	PERSON
admet-881	249	14	t. flanagan	PERSON
admet-881	249	15	m. harwood	PERSON
admet-881	249	16	c. heinen	PERSON
admet-881	249	17	r. holm	PERSON
admet-881	249	18	h. juretschke	PERSON
admet-881	249	19	m. kubbinga	PERSON
admet-881	249	20	a. lindahl	PERSON
admet-881	249	21	v. lukacova	PERSON
admet-881	249	22	s. neuhoff	PERSON
admet-881	249	23	m. nguyen	PERSON
admet-881	249	24	a. peer	PERSON
admet-881	249	25	c. reppas	PERSON
admet-881	249	26	a. hodjegan	PERSON
admet-881	249	27	w. weitschies	PERSON
admet-881	249	28	c. wilson	PERSON
admet-881	249	29	p. zane	PERSON
admet-881	249	30	h. lennernäs	PERSON
admet-881	251	1	european journal of pharmaceutical sciences	ORG
admet-881	251	2	57	DATE
admet-881	251	3	2014	DATE
admet-881	251	4	99	CARDINAL
admet-881	252	1	3	CARDINAL
admet-881	252	2	g.l. amidon	PERSON
admet-881	252	3	h. lennernas	PERSON
admet-881	252	4	v.p. shah	PERSON
admet-881	252	5	j.r. crison	PERSON
admet-881	254	1	12	CARDINAL
admet-881	254	2	1995	DATE
admet-881	254	3	413	CARDINAL
admet-881	255	1	4	CARDINAL
admet-881	255	2	hellriegel	PERSON
admet-881	255	3	t.d. bjornsson	PERSON
admet-881	257	1	60 (1996	DATE
admet-881	257	2	601	CARDINAL
admet-881	258	1	5	CARDINAL
admet-881	258	2	m. sugihara	PERSON
admet-881	258	3	s. takeuchi	PERSON
admet-881	258	4	m. sugita	PERSON
admet-881	258	5	k. higaki	PERSON
admet-881	258	6	m. kataoka	PERSON
admet-881	258	7	s. yamashita	PERSON
admet-881	259	1	113	CARDINAL
admet-881	260	1	12	CARDINAL
admet-881	260	2	2015	CARDINAL
admet-881	260	3	4405-4413	DATE
admet-881	261	1	6	CARDINAL
admet-881	261	2	wu	PERSON
admet-881	261	3	l.z. benet	PERSON
admet-881	261	4	m.f. hebert	PERSON
admet-881	261	5	gupta	GPE
admet-881	261	6	m. rowland	PERSON
admet-881	261	7	d.y. gomez	PERSON
admet-881	261	8	wacher	PERSON
admet-881	263	1	58	DATE
admet-881	263	2	1995	DATE
admet-881	263	3	492	CARDINAL
admet-881	264	1	7	CARDINAL
admet-881	264	2	b.f. jensen	ORG
admet-881	264	3	p.b. brockhoff	PERSON
admet-881	264	4	s.b.	GPE
admet-881	264	5	m. guldbrandt	PERSON
admet-881	264	6	m.s. christensen.	PERSON
admet-881	266	1	48 (2005	DATE
admet-881	266	2	805	CARDINAL
admet-881	267	1	8	CARDINAL
admet-881	267	2	e. sjögren	PERSON
admet-881	267	3	j. westergren	PERSON
admet-881	267	4	i. grant	PERSON
admet-881	267	5	g. hanisch	PERSON
admet-881	267	6	h. lennernäs	PERSON
admet-881	267	7	b. abrahamsson	PERSON
admet-881	267	8	c. tannergren	PERSON
admet-881	269	1	european journal of pharmaceutical sciences	ORG
admet-881	269	2	49	DATE
admet-881	269	3	2013	DATE
admet-881	269	4	679	CARDINAL
admet-881	270	1	9	CARDINAL
admet-881	270	2	williams	PERSON
admet-881	270	3	n.l.	GPE
admet-881	270	4	s.a. charman	ORG
admet-881	270	5	r.m. shanker	ORG
admet-881	270	6	c.w. pouton	PERSON
admet-881	270	7	c.j.	GPE
admet-881	272	1	65	CARDINAL
admet-881	272	2	2013	DATE
admet-881	272	3	315	CARDINAL
admet-881	273	1	10	CARDINAL
admet-881	273	2	c.a. lipinski	PERSON
admet-881	274	1	44	CARDINAL
admet-881	274	2	235	CARDINAL
admet-881	275	1	11	CARDINAL
admet-881	275	2	kenny	PERSON
admet-881	277	1	journal of cheminformatics 11 (	ORG
admet-881	277	2	2019	CARDINAL
admet-881	277	3	1-18	CARDINAL
admet-881	278	1	12	CARDINAL
admet-881	278	2	m.m. hann	PERSON
admet-881	278	3	a.r.	GPE
admet-881	278	4	g. harper	PERSON
admet-881	279	1	discovery	PRODUCT
admet-881	280	1	41	CARDINAL
admet-881	280	2	856	CARDINAL
admet-881	281	1	13	CARDINAL
admet-881	281	2	c. lipinski	PERSON
admet-881	283	1	5	CARDINAL
admet-881	283	2	82	CARDINAL
admet-881	284	1	14	CARDINAL
admet-881	284	2	noyes	ORG
admet-881	284	3	w.r. whitney	GPE
admet-881	286	1	american	NORP
admet-881	286	2	930	CARDINAL
admet-881	287	1	15	CARDINAL
admet-881	287	2	e. brunner	PERSON
admet-881	288	1	reaktionsgeschwindigkeit	PERSON
admet-881	288	2	heterogenen systemen	ORG
admet-881	289	1	zeitschrift für	PERSON
admet-881	289	2	47	CARDINAL
admet-881	289	3	1904	DATE
admet-881	289	4	56	CARDINAL
admet-881	290	1	16	CARDINAL
admet-881	290	2	shah	PERSON
admet-881	290	3	s.b.	GPE
admet-881	290	4	r.h. dave.	PERSON
admet-881	292	1	105	CARDINAL
admet-881	292	2	2016	CARDINAL
admet-881	292	3	10	CARDINAL
admet-881	293	1	17	CARDINAL
admet-881	293	2	dressman	PERSON
admet-881	293	3	g.l. amidon	PERSON
admet-881	293	4	c. reppas	GPE
admet-881	293	5	v.p. shah.	PERSON
admet-881	295	1	15	CARDINAL
admet-881	295	2	1998	DATE
admet-881	295	3	11	CARDINAL
admet-881	296	1	18	CARDINAL
admet-881	296	2	e.r.	GPE
admet-881	296	3	montgomery	GPE
admet-881	297	1	i. solubility	PERSON
admet-881	298	1	journal of pharmaceutical sciences	ORG
admet-881	298	2	105	CARDINAL
admet-881	298	3	2016	CARDINAL
admet-881	299	1	19	CARDINAL
admet-881	299	2	j. siepmann	PERSON
admet-881	299	3	f. siepmann	PERSON
admet-881	301	1	international journal of pharmaceutics 453 (	ORG
admet-881	301	2	2013	DATE
admet-881	301	3	12	CARDINAL
admet-881	302	1	20	CARDINAL
admet-881	302	2	junyaprasert	PERSON
admet-881	302	3	b. morakul	PERSON
admet-881	304	1	asian	NORP
admet-881	304	2	10 (	PERCENT
admet-881	304	3	13	CARDINAL
admet-881	305	1	8(4	CARDINAL
admet-881	305	2	2020	DATE
admet-881	305	3	375	CARDINAL
admet-881	305	4	387	CARDINAL
admet-881	306	1	21	CARDINAL
admet-881	306	2	müller	PERSON
admet-881	306	3	k. peters	PERSON
admet-881	307	1	nanosuspensions	PERSON
admet-881	307	2	i.	PERSON
admet-881	308	1	international journal of pharmaceutics 160	ORG
admet-881	308	2	1998	DATE
admet-881	308	3	229	CARDINAL
admet-881	309	1	22	CARDINAL
admet-881	309	2	serajuddin	ORG
admet-881	311	1	adv drug deliv	ORG
admet-881	311	2	59	CARDINAL
admet-881	311	3	2007	DATE
admet-881	311	4	603	CARDINAL
admet-881	312	1	23	CARDINAL
admet-881	312	2	poovizhi	GPE
admet-881	312	3	w. ng	PERSON
admet-881	312	4	r. tan	PERSON
admet-881	314	1	285	CARDINAL
admet-881	314	2	2015	CARDINAL
admet-881	314	3	2	CARDINAL
admet-881	315	1	24	CARDINAL
admet-881	315	2	g.g. liversidge	GPE
admet-881	315	3	k.c. cundy	PERSON
admet-881	316	1	i.	PERSON
admet-881	317	1	125	CARDINAL
admet-881	317	2	1995	DATE
admet-881	317	3	91	CARDINAL
admet-881	318	1	25	CARDINAL
admet-881	318	2	l.c.	PERSON
admet-881	318	3	alskär	PERSON
admet-881	318	4	c.j.	GPE
admet-881	318	5	c.a. bergström	PERSON
admet-881	320	1	13	CARDINAL
admet-881	320	2	2016	CARDINAL
admet-881	320	3	251	CARDINAL
admet-881	321	1	26	CARDINAL
admet-881	321	2	b. van eerdenbrugh	PERSON
admet-881	321	3	g. van den mooter	PERSON
admet-881	321	4	p. augustijns	PERSON
admet-881	323	1	international journal of pharmaceutics	ORG
admet-881	323	2	364	CARDINAL
admet-881	323	3	2008	DATE
admet-881	323	4	64	CARDINAL
admet-881	324	1	27	CARDINAL
admet-881	324	2	cooper	PERSON
admet-881	326	1	141	CARDINAL
admet-881	326	2	2010	DATE
admet-881	326	3	300	CARDINAL
admet-881	327	1	28	CARDINAL
admet-881	327	2	k. sigfridsson	PERSON
admet-881	327	3	a.j. lundqvist	PERSON
admet-881	327	4	m. strimfors	PERSON
admet-881	329	1	35	CARDINAL
admet-881	329	2	2009	DATE
admet-881	329	3	1479-1486	CARDINAL
admet-881	330	1	29	CARDINAL
admet-881	330	2	k. sugano	PERSON
admet-881	332	1	387	CARDINAL
admet-881	332	2	2010	DATE
admet-881	332	3	103	CARDINAL
admet-881	333	1	30	CARDINAL
admet-881	333	2	s.b.	GPE
admet-881	333	3	d.a. shah	PERSON
admet-881	333	4	r.h. dave.	PERSON
admet-881	335	1	104	CARDINAL
admet-881	335	2	2015	CARDINAL
admet-881	335	3	2094	CARDINAL
admet-881	336	1	31	CARDINAL
admet-881	336	2	f. kesisoglou	PERSON
admet-881	336	3	m. wang	PERSON
admet-881	336	4	k. galipeau	PERSON
admet-881	336	5	p. harmon	PERSON
admet-881	336	6	g. okoh	PERSON
admet-881	336	7	w. xu	PERSON
admet-881	338	1	108	CARDINAL
admet-881	338	2	2019) 29172925	DATE
admet-881	339	1	32	CARDINAL
admet-881	339	2	s. dadashzadeh	PERSON
admet-881	339	3	m. osouli	PERSON
admet-881	339	4	m.s.	PERSON
admet-881	339	5	daryabari	PERSON
admet-881	339	6	a. haeri	PERSON
admet-881	341	1	2020	DATE
admet-881	342	1	33	CARDINAL
admet-881	342	2	s. colombo	PERSON
admet-881	342	3	m. brisander	PERSON
admet-881	342	4	j. haglöf	PERSON
admet-881	342	5	p. andersson	PERSON
admet-881	342	6	j. østergaard	PERSON
admet-881	342	7	m. malmsten	PERSON
admet-881	344	1	international journal of pharmaceutics	ORG
admet-881	344	2	494	CARDINAL
admet-881	344	3	2015	CARDINAL
admet-881	344	4	205	CARDINAL
admet-881	345	1	34	CARDINAL
admet-881	345	2	jinno	PERSON
admet-881	345	3	n. kamada	PERSON
admet-881	345	4	m. miyake	PERSON
admet-881	345	5	k. yamada	PERSON
admet-881	345	6	t. mukai	ORG
admet-881	345	7	m. odomi	PERSON
admet-881	345	8	h. toguchi	PERSON
admet-881	345	9	g.g. liversidge	GPE
admet-881	345	10	k. higaki	PERSON
admet-881	345	11	t. kimura	PERSON
admet-881	347	1	111	CARDINAL
admet-881	347	2	2006	DATE
admet-881	347	3	56	CARDINAL
admet-881	348	1	35	CARDINAL
admet-881	348	2	e. merisko-liversidge	PERSON
admet-881	348	3	g.g. liversidge	GPE
admet-881	348	4	e.r. cooper	PERSON
admet-881	349	1	nanosizing	PERSON
admet-881	350	1	european journal of pharmaceutical sciences	ORG
admet-881	350	2	18 (2003	DATE
admet-881	350	3	113	CARDINAL
admet-881	351	1	36	CARDINAL
admet-881	351	2	r. müller	PERSON
admet-881	351	3	c. jacobs	PERSON
admet-881	351	4	o. kayser	PERSON
admet-881	352	1	nanosuspensions	PERSON
admet-881	353	1	adv drug deliv	ORG
admet-881	353	2	47 (2001	DATE
admet-881	353	3	3	CARDINAL
admet-881	354	1	37	CARDINAL
admet-881	354	2	j. brouwers	PERSON
admet-881	354	3	m. corsetti	PERSON
admet-881	354	4	p. augustijns	PERSON
admet-881	356	1	european journal of pharmaceutical sciences	ORG
admet-881	356	2	77	CARDINAL
admet-881	356	3	2015	CARDINAL
admet-881	356	4	40	CARDINAL
admet-881	357	1	38	CARDINAL
admet-881	357	2	k. sugano	PERSON
admet-881	359	1	7 (2010	DATE
admet-881	359	2	1362-1373	CARDINAL
admet-881	360	1	39	CARDINAL
admet-881	360	2	g.e. amidon	PERSON
admet-881	360	3	w.i. higuchi	GPE
admet-881	361	1	sci 71 (	ORG
admet-881	361	2	1982	DATE
admet-881	361	3	77	CARDINAL
admet-881	362	1	40	CARDINAL
admet-881	362	2	lai	ORG
admet-881	362	3	d.e. o'hanlon	ORG
admet-881	362	4	s. harrold	PERSON
admet-881	362	5	s.t.	PERSON
admet-881	363	1	wang	PERSON
admet-881	363	2	r. cone	PERSON
admet-881	363	3	j. hanes	PERSON
admet-881	365	1	the national academy of sciences 104 (	ORG
admet-881	365	2	2007	DATE
admet-881	365	3	1482-1487	CARDINAL
admet-881	366	1	h. lennernäs et	PERSON
admet-881	366	2	al. admet &	ORG
admet-881	366	3	8(4	CARDINAL
admet-881	366	4	2020	DATE
admet-881	366	5	375	CARDINAL
admet-881	366	6	41	CARDINAL
admet-881	366	7	k. netsomboon	PERSON
admet-881	366	8	a. bernkop-schnürch	PERSON
admet-881	367	1	mucoadhesive	PERSON
admet-881	368	1	european journal of pharmaceutics	ORG
admet-881	368	2	biopharmaceutics	ORG
admet-881	368	3	98	CARDINAL
admet-881	368	4	2016	CARDINAL
admet-881	368	5	76-89	DATE
admet-881	369	1	42	CARDINAL
admet-881	369	2	j. leal	PERSON
admet-881	369	3	h.d. smyth	ORG
admet-881	369	4	d. ghosh	PERSON
admet-881	371	1	international journal of pharmaceutics	ORG
admet-881	371	2	532	CARDINAL
admet-881	371	3	2017	CARDINAL
admet-881	371	4	555	CARDINAL
admet-881	372	1	43	CARDINAL
admet-881	372	2	levitt	PERSON
admet-881	372	3	a. strocchi	PERSON
admet-881	372	4	d.g. levitt	PERSON
admet-881	374	1	american journal of physiology-gastrointestinal	ORG
admet-881	374	2	262	CARDINAL
admet-881	374	3	1992	DATE
admet-881	374	4	g593-g596	ORG
admet-881	375	1	44	CARDINAL
admet-881	375	2	levitt	PERSON
admet-881	375	3	j.k.	PERSON
admet-881	375	4	furne	PERSON
admet-881	377	1	103	CARDINAL
admet-881	377	2	1992	DATE
admet-881	377	3	1460-1466	CARDINAL
admet-881	378	1	45	CARDINAL
admet-881	378	2	d. dahlgren	PERSON
admet-881	378	3	m. sjöblom	PERSON
admet-881	378	4	h. lennernäs	PERSON
admet-881	380	1	european journal of pharmaceutics	ORG
admet-881	380	2	biopharmaceutics	ORG
admet-881	380	3	142	CARDINAL
admet-881	380	4	2019	CARDINAL
admet-881	380	5	411	CARDINAL
admet-881	381	1	46	CARDINAL
admet-881	381	2	h. lennernäs	PERSON
admet-881	383	1	european	NORP
admet-881	383	2	3 (1995	DATE
admet-881	383	3	247	CARDINAL
admet-881	384	1	47	CARDINAL
admet-881	384	2	bajka	GPE
admet-881	384	3	n.m. rigby	PERSON
admet-881	384	4	k.l. cross	ORG
admet-881	384	5	a. macierzanka	PERSON
admet-881	384	6	a.r.	PERSON
admet-881	384	7	mackie	ORG
admet-881	386	1	135	CARDINAL
admet-881	386	2	2015	CARDINAL
admet-881	387	1	48	CARDINAL
admet-881	387	2	a. einstein	PERSON
admet-881	389	1	annalen der physik	PERSON
admet-881	389	2	17 (1905	DATE
admet-881	389	3	549	CARDINAL
admet-881	390	1	49	CARDINAL
admet-881	390	2	y. wang	PERSON
admet-881	390	3	brasseur	PERSON
admet-881	391	1	three	CARDINAL
admet-881	392	1	95	CARDINAL
admet-881	392	2	062412	DATE
admet-881	393	1	50	CARDINAL
admet-881	393	2	d. dahlgren	GPE
admet-881	393	3	c. roos	PERSON
admet-881	393	4	johansson	GPE
admet-881	393	5	a. lundqvist	PERSON
admet-881	393	6	m. sjöblom	PERSON
admet-881	393	7	e. sjögren	PERSON
admet-881	394	1	three	CARDINAL
admet-881	394	2	six	CARDINAL
admet-881	395	1	547	CARDINAL
admet-881	395	2	2018	DATE
admet-881	395	3	158	CARDINAL
admet-881	396	1	51	CARDINAL
admet-881	396	2	e. sjödin	PERSON
admet-881	396	3	h. fritsch	PERSON
admet-881	396	4	u.g. eriksson	ORG
admet-881	396	5	a. nordgren	PERSON
admet-881	396	6	l. knutson	PERSON
admet-881	396	7	h. lennernäs	PERSON
admet-881	397	1	ximelagatran	GPE
admet-881	398	1	36 (2008	DATE
admet-881	398	2	1519-1528	DATE
admet-881	399	1	52	CARDINAL
admet-881	399	2	l. bønløkke	PERSON
admet-881	399	3	l. hovgaard	PERSON
admet-881	399	4	kristensen	PERSON
admet-881	399	5	l. knutson	PERSON
admet-881	399	6	h. lennernäs	PERSON
admet-881	400	1	two	CARDINAL
admet-881	401	1	european	NORP
admet-881	401	2	12 (2001	DATE
admet-881	401	3	239	CARDINAL
admet-881	402	1	53	CARDINAL
admet-881	402	2	l. bønløkke	PERSON
admet-881	402	3	f.n. christensen	GPE
admet-881	402	4	l. knutson	PERSON
admet-881	402	5	h.g. kristensen	PERSON
admet-881	402	6	h. lennernäs	PERSON
admet-881	404	1	14 (1997	DATE
admet-881	404	2	1490-1492	CARDINAL
admet-881	405	1	54	CARDINAL
admet-881	405	2	d. dahlgren	GPE
admet-881	405	3	c. roos	PERSON
admet-881	405	4	e. sjögren	PERSON
admet-881	405	5	h. lennernäs	PERSON
admet-881	407	1	104	CARDINAL
admet-881	408	1	55	CARDINAL
admet-881	408	2	e.m. persson	ORG
admet-881	408	3	a. nordgren	PERSON
admet-881	408	4	l. knutson	PERSON
admet-881	408	5	c. öhgren	GPE
admet-881	408	6	s. forssén	PERSON
admet-881	408	7	h. lennernäs	PERSON
admet-881	408	8	b. abrahamsson	PERSON
admet-881	410	1	european journal of pharmaceutical sciences	ORG
admet-881	410	2	34 (2008	DATE
admet-881	410	3	22	CARDINAL
admet-881	411	1	56	CARDINAL
admet-881	411	2	h. lennernäs	PERSON
admet-881	411	3	ö. ahrenstedt	GPE
admet-881	411	4	r. hällgren	PERSON
admet-881	411	5	l. knutson	PERSON
admet-881	411	6	m. ryde	PERSON
admet-881	411	7	l.k. paalzow	PERSON
admet-881	413	1	9	CARDINAL
admet-881	413	2	1992	DATE
admet-881	413	3	1243	CARDINAL
admet-881	414	1	57	CARDINAL
admet-881	414	2	s.c.	ORG
admet-881	414	3	sutton	GPE
admet-881	414	4	m. rinaldi	PERSON
admet-881	414	5	k. vukovinsky	PERSON
admet-881	415	1	14c-peg-3350	DATE
admet-881	416	1	3 (2001	DATE
admet-881	416	2	93	DATE
admet-881	417	1	58	CARDINAL
admet-881	417	2	h. lennernäs	PERSON
admet-881	417	3	i.d. lee	PERSON
admet-881	417	4	g.l. amidon	PERSON
admet-881	419	1	49	DATE
admet-881	419	2	1997	DATE
admet-881	419	3	682	CARDINAL
admet-881	420	1	8(4	CARDINAL
admet-881	420	2	2020	DATE
admet-881	420	3	375	CARDINAL
admet-881	420	4	389	CARDINAL
admet-881	420	5	59	CARDINAL
admet-881	422	1	49	DATE
admet-881	422	2	1997	DATE
admet-881	422	3	627	CARDINAL
admet-881	423	1	60	CARDINAL
admet-881	423	2	e. sjögren	PERSON
admet-881	423	3	j. westergren	PERSON
admet-881	423	4	i. grant	PERSON
admet-881	423	5	g. hanisch	PERSON
admet-881	423	6	h. lennernäs	PERSON
admet-881	423	7	b. abrahamsson	PERSON
admet-881	423	8	c. tannergren	PERSON
admet-881	425	1	european journal of pharmaceutical sciences	ORG
admet-881	425	2	2013	DATE
admet-881	426	1	61	CARDINAL
admet-881	426	2	dando	ORG
admet-881	426	3	c.m. perry	PERSON
admet-881	426	4	aprepitant	PERSON
admet-881	427	1	64	CARDINAL
admet-881	427	2	2004	DATE
admet-881	427	3	777	CARDINAL
admet-881	428	1	62	CARDINAL
admet-881	428	2	a. bergendal	PERSON
admet-881	428	3	h. lennernäs	PERSON
admet-881	428	4	b. abrahamsson	PERSON
admet-881	430	1	6	CARDINAL
admet-881	430	2	2009	DATE
admet-881	430	3	60-73	CARDINAL
admet-881	431	1	63	CARDINAL
admet-881	431	2	c. roos	PERSON
admet-881	431	3	d. dahlgren	GPE
admet-881	431	4	s. berg	PERSON
admet-881	431	5	j. westergren	PERSON
admet-881	431	6	b. abrahamsson	PERSON
admet-881	431	7	c. tannergren	PERSON
admet-881	431	8	e. sjögren	PERSON
admet-881	431	9	h. lennernäs	PERSON
admet-881	432	1	aprepitant nanoformulations	PERSON
admet-881	433	1	14	DATE
admet-881	433	2	2017	CARDINAL
admet-881	433	3	4233-4242	DATE
admet-881	434	1	64	CARDINAL
admet-881	434	2	sanchez	PERSON
admet-881	434	3	r.w	GPE
admet-881	434	4	wang	PERSON
admet-881	434	5	d.j. newton	PERSON
admet-881	434	6	r. bakhtiar	PERSON
admet-881	435	1	chiu	PERSON
admet-881	435	2	d.c. evans	PERSON
admet-881	435	3	s.-e.w	PERSON
admet-881	435	4	huskey	PERSON
admet-881	436	1	3a4	CARDINAL
admet-881	437	1	32 (2004	DATE
admet-881	437	2	1287	CARDINAL
admet-881	438	1	65	CARDINAL
admet-881	438	2	r. hargreaves	PERSON
admet-881	439	1	ferreira	PERSON
admet-881	439	2	d. hughes	PERSON
admet-881	439	3	j. brands	ORG
admet-881	439	4	j. hale	PERSON
admet-881	439	5	b. mattson	PERSON
admet-881	439	6	s. mills	PERSON
admet-881	440	1	first	ORDINAL
admet-881	441	1	the new york academy of sciences 1222 (	ORG
admet-881	441	2	2011	DATE
admet-881	441	3	40	CARDINAL
admet-881	442	1	66	CARDINAL
admet-881	442	2	augustijns	GPE
admet-881	442	3	t.p.	GPE
admet-881	442	4	gan	PERSON
admet-881	442	5	r.w. hendren	PERSON
admet-881	442	6	d.r.	GPE
admet-881	444	1	197	CARDINAL
admet-881	444	2	1993	DATE
admet-881	444	3	360-365	CARDINAL
admet-881	445	1	67	CARDINAL
admet-881	445	2	k. ueda	PERSON
admet-881	445	3	r. hori	PERSON
admet-881	445	4	t. komano	ORG
admet-881	447	1	268	CARDINAL
admet-881	447	2	1993	DATE
admet-881	447	3	6077-6080	CARDINAL
admet-881	448	1	68	CARDINAL
admet-881	448	2	fischer	PERSON
admet-881	448	3	u.a. meyer	ORG
admet-881	449	1	630635	DATE
admet-881	450	1	69	CARDINAL
admet-881	450	2	a. munoz	PERSON
admet-881	450	3	j. guichard	PERSON
admet-881	452	1	110	CARDINAL
admet-881	452	2	1994	DATE
admet-881	453	1	70	CARDINAL
admet-881	453	2	r. takano	PERSON
admet-881	453	3	k. furumoto	PERSON
admet-881	453	4	k. shiraki	PERSON
admet-881	453	5	n. takata	PERSON
admet-881	453	6	y. hayashi	PERSON
admet-881	453	7	y. aso	PERSON
admet-881	453	8	s. yamashita	PERSON
admet-881	455	1	25	CARDINAL
admet-881	455	2	2334-2344	DATE
admet-881	456	1	71	CARDINAL
admet-881	456	2	l. jia	PERSON
admet-881	456	3	h. wong	PERSON
admet-881	456	4	c. cerna	GPE
admet-881	456	5	s.d.	PERSON
admet-881	456	6	weitman	PERSON
admet-881	457	1	301029	DATE
admet-881	458	1	19	CARDINAL
admet-881	459	1	72	CARDINAL
admet-881	459	2	e. jantratid	PERSON
admet-881	459	3	f. kesisoglou	PERSON
admet-881	459	4	c. reppas	PERSON
admet-881	459	5	j.b. dressman	PERSON
admet-881	461	1	european journal of pharmaceutics	ORG
admet-881	461	2	biopharmaceutics	ORG
admet-881	461	3	76 (	DATE
admet-881	461	4	2010	DATE
admet-881	461	5	95	CARDINAL
admet-881	462	1	73	CARDINAL
admet-881	462	2	y. wu	PERSON
admet-881	462	3	a. loper	PERSON
admet-881	462	4	e. landis	PERSON
admet-881	462	5	l. hettrick	PERSON
admet-881	462	6	l. novak	PERSON
admet-881	462	7	k. lynn	PERSON
admet-881	462	8	c. chen	PERSON
admet-881	462	9	k. thompson	PERSON
admet-881	462	10	r. higgins	PERSON
admet-881	463	1	biopharmaceutics	ORG
admet-881	464	1	285	CARDINAL
admet-881	464	2	2004	DATE
admet-881	464	3	135	CARDINAL
admet-881	465	1	74	CARDINAL
admet-881	465	2	majumdar	PERSON
admet-881	465	3	l. howard	PERSON
admet-881	465	4	m.r. goldberg	PERSON
admet-881	465	5	l. hickey	PERSON
admet-881	465	6	m. constanzer	PERSON
admet-881	466	1	rothenberg	PERSON
admet-881	466	2	t.m. crumley	PERSON
admet-881	466	3	d. panebianco	PERSON
admet-881	466	4	t.e. bradstreet	PERSON
admet-881	466	5	a.j. bergman	PERSON
admet-881	468	1	46	DATE
admet-881	468	2	2006	DATE
admet-881	468	3	291	CARDINAL
admet-881	469	1	75	CARDINAL
admet-881	469	2	f. kesisoglou	PERSON
admet-881	469	3	s. panmai	PERSON
admet-881	469	4	y. wu	PERSON
admet-881	470	1	nanosizing	PERSON
admet-881	471	1	adv drug deliv	ORG
admet-881	471	2	59	CARDINAL
admet-881	471	3	2007	DATE
admet-881	471	4	631-644	CARDINAL
admet-881	472	1	76	CARDINAL
admet-881	472	2	p. artursson	PERSON
admet-881	474	1	106	CARDINAL
admet-881	474	2	2016	CARDINAL
admet-881	474	3	256	CARDINAL
admet-881	475	1	h. lennernäs et	PERSON
admet-881	475	2	al. admet &	ORG
admet-881	475	3	8(4	CARDINAL
admet-881	475	4	2020	DATE
admet-881	475	5	375	CARDINAL
admet-881	476	1	77	CARDINAL
admet-881	476	2	sharpe	PERSON
admet-881	476	3	x. qin	PERSON
admet-881	476	4	q. lu	PERSON
admet-881	476	5	e. feketeova	PERSON
admet-881	476	6	d.c. palange	GPE
admet-881	476	7	w. dong	PERSON
admet-881	476	8	sheth	PERSON
admet-881	476	9	m.a. lee	PERSON
admet-881	476	10	d. reino	PERSON
admet-881	477	1	xu	PERSON
admet-881	479	1	augusta	GPE
admet-881	479	2	ga	ORG
admet-881	480	1	34	CARDINAL
admet-881	480	2	2010	DATE
admet-881	480	3	475	CARDINAL
admet-881	481	1	78	CARDINAL
admet-881	481	2	d. dahlgren	GPE
admet-881	481	3	e. sjögren	PERSON
admet-881	481	4	m. sjöblom	PERSON
admet-881	481	5	m. hedeland	PERSON
admet-881	481	6	h. lennernäs	PERSON
admet-881	482	1	nanosuspensions	PERSON
admet-881	483	1	european journal of pharmaceutics	ORG
admet-881	483	2	132	CARDINAL
admet-881	483	3	2018	DATE
admet-881	483	4	222	CARDINAL
admet-881	484	1	79	CARDINAL
admet-881	485	1	chiu	PERSON
admet-881	485	2	k. higaki	PERSON
admet-881	485	3	b.l. neudeck	GPE
admet-881	485	4	barnett	ORG
admet-881	485	5	l.s.	GPE
admet-881	485	6	g.l. amidon	PERSON
admet-881	487	1	20	CARDINAL
admet-881	487	2	2003	DATE
admet-881	487	3	749	CARDINAL
admet-881	488	1	80	CARDINAL
admet-881	490	1	xenobiotica 37 (	FAC
admet-881	490	2	2007	DATE
admet-881	491	1	81	CARDINAL
admet-881	491	2	j. westergren	PERSON
admet-881	491	3	d. dahlgren	GPE
admet-881	491	4	h. lennernäs	PERSON
admet-881	491	5	e. sjögren	PERSON
admet-881	493	1	european journal of pharmaceutics	ORG
admet-881	493	2	biopharmaceutics	ORG
admet-881	493	3	133	CARDINAL
admet-881	493	4	2018	DATE
admet-881	493	5	70-76	DATE
admet-881	494	1	82	CARDINAL
admet-881	494	2	s. suarez	PERSON
admet-881	494	3	m. kakhi	PERSON
admet-881	494	4	a. olivares-morales	PERSON
admet-881	494	5	x. pepin	PERSON
admet-881	494	6	e. sjögren	PERSON
admet-881	494	7	e. tsakalozou	PERSON
admet-881	494	8	m. li	PERSON
admet-881	495	1	2019	DATE
admet-881	496	1	83	CARDINAL
admet-881	496	2	h. lennernäs	PERSON
admet-881	499	1	10	CARDINAL
admet-881	499	2	1993	DATE
admet-881	499	3	879	CARDINAL
admet-881	500	1	84	CARDINAL
admet-881	500	2	a. heggelund	PERSON
admet-881	500	3	k. kylberg‐hanssen	PERSON
admet-881	500	4	lundborg	ORG
admet-881	501	1	three	CARDINAL
admet-881	502	1	biopharmaceutics	ORG
admet-881	502	2	11	CARDINAL
admet-881	502	3	1990	DATE
admet-881	502	4	607	CARDINAL
admet-881	503	1	85	CARDINAL
admet-881	503	2	t. zhu	GPE
admet-881	503	3	j.c. ansquer	PERSON
admet-881	503	4	m.t. kelly	GPE
admet-881	503	5	d.j.	GPE
admet-881	503	6	r.s.	PERSON
admet-881	503	7	pradhan	PERSON
admet-881	505	1	50	CARDINAL
admet-881	505	2	2010	DATE
admet-881	505	3	914	CARDINAL
admet-881	506	1	86	CARDINAL
admet-881	506	2	yousaf	PERSON
admet-881	506	3	d.w. kim	PERSON
admet-881	507	1	c.s. yong	PERSON
admet-881	507	2	j.o. kim	GPE
admet-881	510	1	nanomedicine 10 (	LAW
admet-881	510	2	1819	DATE
admet-881	511	1	87	CARDINAL
admet-881	513	1	39	CARDINAL
admet-881	513	2	1960	DATE
admet-881	513	3	809	CARDINAL
admet-881	514	1	88	CARDINAL
admet-881	514	2	a. johansson	PERSON
admet-881	514	3	s.-m	LANGUAGE
admet-881	515	1	e. hellquist	PERSON
admet-881	515	2	h. lennernäs	PERSON
admet-881	515	3	h. askmark	PERSON
admet-881	516	1	complexity of motor	ORG
admet-881	517	1	35	CARDINAL
admet-881	517	2	2012	DATE
admet-881	517	3	6	CARDINAL
admet-881	518	1	89	CARDINAL
admet-881	518	2	h. askmark	PERSON
admet-881	518	3	c. gomes	PERSON
admet-881	518	4	trolin	GPE
admet-881	518	5	t. knutson	PERSON
admet-881	518	6	h. lennernäs	PERSON
admet-881	518	7	c. nyström	PERSON
admet-881	518	8	s.-m	LANGUAGE
admet-881	521	1	26	CARDINAL
admet-881	521	2	2003	DATE
admet-881	521	3	156	CARDINAL
admet-881	522	1	90	CARDINAL
admet-881	522	2	d. fleisher	PERSON
admet-881	522	3	c. li	PERSON
admet-881	522	4	y. zhou	PERSON
admet-881	523	1	pao	ORG
admet-881	523	2	a. karim	PERSON
admet-881	525	1	36 (1999	DATE
admet-881	525	2	233	CARDINAL
admet-881	526	1	2020	DATE
admet-881	526	2	iapc	ORG
admet-881	526	3	zagreb	GPE
admet-881	526	4	croatia	GPE
admet-881	527	1	http://creativecommons.org/licenses/by/3.0/	ORG
admet-881	527	2	http://creativecommons.org/licenses/by/3.0/	ORG